Personalized neoantigen mRNA vaccines — the individually designed cancer vaccines encoding 10-20 patient-specific tumor mutations manufactured within 6-8 weeks from tumor biopsy and sequencing — represent the most transformative modality in the neoantigen targeted therapy market, with the Neoantigen Targeted Therapy Market reflecting personalized mRNA as the precision...